Ceritinib (Cerini) 150mg*50's | TLPH Laos Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Cerini (Laos)

Cerini is a Laotian generic of ceritinib produced by Trans Continental Life Science & Pharmaceuticals (TLPH), a Laos-based manufacturer serving the Southeast Asian oncology market. Each capsule contains 150 mg of ceritinib, with 50 capsules per pack. As a generic of the second-generation ALK inhibitor, Cerini provides an affordable alternative to the originator for patients with ALK-positive lung cancer.

What Is Cerini Used For?

Cerini is used for ALK-positive metastatic non-small cell lung cancer, especially after progression on crizotinib. It offers an oral, targeted option for this lung-cancer subtype, and the 50-capsule pack is a convenient mid-size supply that balances cost with the convenience of a longer refill interval.

How Does Ceritinib (Cerini) Work?

Ceritinib is a selective ALK inhibitor. It blocks anaplastic lymphoma kinase, the abnormal enzyme that drives growth in ALK-rearranged lung cancers, and remains active against many crizotinib-resistant ALK mutations. This dual strength — potent ALK blockade plus coverage of resistance mutations — is what makes second-generation inhibitors like ceritinib valuable after first-line therapy fails.

Indications

The approved indication is ALK-positive metastatic NSCLC, confirmed by molecular testing. Cerini is used after crizotinib progression and, where locally approved, as first-line therapy. Treatment requires a prescription and supervision by an oncology specialist.

Dosage

The standard dose is 450 mg (three capsules) once daily with food, or 750 mg once daily fasting per the original label. A 50-capsule pack lasts about 16 days at the 450 mg dose. Dosing is adjusted by the treating physician according to side effects and liver-function results.

Side Effects

Frequent side effects are diarrhoea, nausea, vomiting, abdominal pain, fatigue and decreased appetite. Important effects include liver enzyme elevations, high blood sugar, QT-interval prolongation and, rarely, interstitial lung disease. Patients undergo regular liver-function, blood-glucose and ECG monitoring and should report persistent symptoms promptly.

Storage

Store Cerini capsules at room temperature in a dry place, in the original packaging and out of reach of children. Do not use beyond the expiry date.

Why Choose Cerini Through GLT?

Cerini offers ceritinib at a price well below originator levels, making ALK-targeted therapy affordable for patients across Southeast Asia and beyond. GLT sources this Laotian generic through verified channels, supplying genuine TLPH product with documentation and shipping from a Hong Kong-licensed facility.

How to Order

To order Cerini (ceritinib) from GLT, contact us on WhatsApp at +86 15234153837 or by email at [email protected]. We confirm availability, pricing and delivery to your country.

FAQ

Is Cerini a generic of Zykadia? Yes, Cerini contains the same active ingredient ceritinib as the originator Zykadia, at a lower price.

Who makes Cerini? Cerini is manufactured by Trans Continental Life Science & Pharmaceuticals (TLPH) in Laos.

How long does a 50-capsule pack last? At 450 mg once daily (three capsules), a 50-capsule pack lasts about 16 days.

Related Oncology Products

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...

Barinat (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Natco Pharma Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Natco Pharma Limited (India) — an affordable alternative to Olumiant...

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...